Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Molecular Oncology is Scopus-indexed (Q1, CiteScore 9.4), WoS SCIE, DOAJ. Published by John Wiley and Sons Ltd.
Checked against the index lists dated .
ISSN 1574-7891Verify ISSN ↗1878-0261Verify ISSN ↗
Publisher: John Wiley and Sons Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Genetics | 40 / 357 | 88th | Q1 |
| Oncology | 62 / 428 | 85th | Q1 |
| Molecular Medicine | 38 / 179 | 79th | Q1 |
| Cancer Research | 57 / 233 | 75th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2007–present, best quartile Q1, CiteScore 9.4.
Molecular Oncology is Q1 in Genetics (rank 40 of 357), Q1 in Oncology (rank 62 of 428) and Q1 in Molecular Medicine (rank 38 of 179), by CiteScore 2025. It is ranked in 4 subject areas in all.
Molecular Oncology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 9.4, which places it in quartile Q1 at the 88th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.738, quartile Q1, with an H-index of 130.
The publisher lists an article processing charge of about US$4,300 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Molecular Oncology is published by John Wiley and Sons Ltd. Its print ISSN is 1574-7891 and its online ISSN is 1878-0261.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Molecular Oncology has an h-index of 150 and a 2-year mean of 3.33 citations per paper (OpenAlex). Its Scopus CiteScore is 9.4, quartile Q1. On 2-year citations it ranks #122 of 353 Scopus journals in Genetics.
Molecular Oncology published 242 papers in 2025; its busiest recent year was 2020 with 280. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2026), authors are most often from United States (16.5%), Germany (11.2%) and Italy (9.9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 47 retracted papers are recorded (14.4 per 1,000 papers). The Problematic Paper Screener flags 2 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.